10x Genomics

10x Genomics operates as a biotechnology company headquartered in the United States, specifically within California. Its activities include conducting research, notably during critical pandemic-related efforts focused on COVID-19. The company handles sensitive data and utilizes secure storage systems as part of its operational infrastructure. This operational scope involves managing significant volumes of proprietary and potentially confidential information directly tied to its research endeavors.

The organisation experienced a significant cybersecurity incident on April 1, 2020. The REvil ransomware group targeted 10x Genomics using Sodinokibi malware. This attack resulted in unauthorized access to the company's operational systems and the exfiltration of over 1 terabyte of data. The attackers threatened to release the stolen information publicly unless contacted and subsequently leaked some of the compromised files on dark web platforms. These disclosed materials were later removed by the hosting services for violating terms of service. 10x Genomics formally acknowledged this breach through regulatory filings, confirming the compromise of sensitive data during its pandemic research activities. The incident underscores the cybersecurity risks faced by entities engaged in vital scientific research involving valuable intellectual property and sensitive operational details.